LEES ANDREW has a total of 20 patent applications. Its first patent ever was published in 1996. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals, machines and biotechnology are JAPAN BCG LAB, WAKUNAGA OF AMERICA CO LTD and ARROWDEAN LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | United States | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | EPO (European Patent Office) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Macromolecular chemistry and polymers | |
#6 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Lees Andrew | 19 |
#2 | Mond James J | 6 |
#3 | Taubman Martin A | 5 |
#4 | Smith Daniel J | 5 |
#5 | Henry M Jackson | 1 |
#6 | Wagner Hildebert | 1 |
#7 | Snapper Clifford M | 1 |
#8 | Van Der Giessen Rob | 1 |
#9 | Simon Raphael | 1 |
#10 | Olanow Waren C | 1 |
Publication | Filing date | Title |
---|---|---|
WO2012061400A2 | Method for reduction of free polysaccharide in polysaccharide-protein vaccines reactions using ion-exchange matrices | |
US2012288518A1 | Activation of polysaccharides via the cyanylating agent, 1-cyano-4-pyrrolidinopyridinium tetrafluoroborate (CPPT), in the preparation of polysaccharide/protein conjugate vaccines | |
US2012214187A1 | Method for Enhancing the Sensitivity of Antibody Based Assays | |
WO9952548A2 | Conjugate vaccines for the prevention of dental caries |